Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 213976, 4 pages
http://dx.doi.org/10.1155/2013/213976
Research Article

The Electrophysiological Effects of Qiliqiangxin on Cardiac Ventricular Myocytes of Rats

1Department of Cardiology, Shanghai Tenth People’s Hospital of Tongji University, 301 Yanchang Road, Shanghai 200072, China
2Department of Traditional Chinese Medicine, Shanghai Tenth People’s Hospital of Tongji University, 301 Yanchang Road, Shanghai 200072, China
3Zhengzhou Second People’s Hospital, 90 Hanghai Road, Zhengzhou, Henan 450015, China
4Department of Cardiology, General Hospital of Beijing Military Command, No. 5 Nanmencang, Dongsishitiao, Dongcheng District, Beijing 100007, China

Received 2 May 2013; Revised 24 June 2013; Accepted 2 July 2013

Academic Editor: Hao Xu

Copyright © 2013 Yidong Wei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. L. Wu, C. H. Gu, G. C. Xu, C. Wei, and X. D. Gao, “Clinical observation of randomized double-blind and multicenter trial on Qiliqiangxin capsule in the treatment of chronic heart failure,” Chinese Journal of Difficult and Complicated Cases, vol. 6, pp. 55–58, 2007. View at Google Scholar
  2. J. H. Ling, P. B. Wu, W. Y. Cai, X. B. Xu, M. R. Zhuang, and C. L. Li, “Therapeutic effect of Qiliqiangxin capsule on the patients with chronic congestive heart failure,” Chinese Journal of Difficult and Complicated Cases, vol. 5, pp. 49–55, 2008. View at Google Scholar
  3. H. Xiao, Y. Song, Y. Li, Y. Liao, and J. Chen, “Qiliqiangxin regulates the balance between tumor necrosis factor-α and interleukin-10 and improves cardiac function in rats with myocardial infarction,” Cellular Immunology, vol. 260, no. 1, pp. 51–55, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. D. M. Bers, “Calcium cycling and signaling in cardiac myocytes,” Annual Review of Physiology, vol. 70, pp. 23–49, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Wei, X. Liu, L. Hou, W. Che, E. The, and M. V. Jhummon, “Qiliqiangxin affects L type Ca2+ current in the normal and hypertrophied rat heart,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 131830, 4 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. J.-P. Benitah, A. M. Gomez, and P. Bailly, “Heterogeneity of the early outward current in ventricular cells isolated from normal and hypertrophied rat hearts,” The Journal of Physiology, vol. 469, pp. 111–138, 1993. View at Google Scholar · View at Scopus
  7. Z. Zhao, W. Wang, and F. Wang, “Effects of astragaloside IV on heart failure in rats,” Chinese Medicine, vol. 4, article 6, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Lin, C. Chan, C. Yang, Y. Wang, H. Chiou, and Y. Su, “A cardiotonic Chinese herb, a new medical treatment choice for portal hypertension?” Experimental Biology and Medicine, vol. 232, no. 4, pp. 557–564, 2007. View at Google Scholar · View at Scopus
  9. N. Li, Y. Huo, K. Ma, Q. Sun, and J. Pu, “Effects of solution of dry powder of ShenSongYangXin capsule on sodium current and L-type calcium current in ventricular myocytes: experiment with guinea pig,” Zhonghua Yi Xue Za Zhi, vol. 87, no. 14, pp. 995–998, 2007. View at Google Scholar · View at Scopus